European journal of cancer (Oxford, England : 1990)HumansEsophageal NeoplasmsProgression-Free SurvivalImmunotherapyStomach Neoplasms
Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysis.
Alberto Giovanni Leone, Fausto Petrelli, Samuel J Klempner, Elizabeth C Smyth, Raghav Sundar, Florian Lordick, Sylvie Lorenzen, Micheal Masetti, Radka Obermannova, Maria Alsina, Yelena Y Janjigian, Filippo Pietrantonio
Published: 202610.1016/j.ejca.2025.116155
Abstract
BACKGROUND: Immune checkpoint inhibitors (ICIs)-based regimens are the first-line standard of care for most patients with advanced gastroesophageal adenocarcinoma (GEA) and esophageal squamous cell carcinoma (ESCC). The efficacy of these treatments o…
Preview only. Read the full abstract at the source